Lilly and Merck pair ‘breakthrough’ therapies in latest cancer collaboration

Damian Garde

Eli and are expanding their oncology partnership to study a combination of the former's top prospect with the latter's blockbuster immunotherapy.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS